Mignar 25 Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Miglitol (25mg)
Overview Mignar 25 Tablet
Diabex 25mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. Prescribed when dietary modifications and other anti-diabetic therapies prove insufficient, Diabex 25mg should be ingested immediately prior to, or with the initial bite of, each meal. Dosage frequency is determined individually by your physician to optimize glycemic control, potentially increasing gradually. Discontinuation requires medical consultation; abrupt cessation risks dangerously elevated blood glucose, potentially leading to severe complications like nephropathy and vision impairment. This medication is a component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Consistent blood glucose monitoring is crucial during treatment. Common adverse effects include dermatological reactions (rash), flatulence, abdominal discomfort, and diarrhea. Consult your doctor if these symptoms persist or are bothersome. Diabex 25mg, in isolation, does not induce hypoglycemia. However, concomitant use with other anti-diabetic agents (particularly insulin or sulfonylureas) elevates the risk of hypoglycemia, requiring treatment with pure glucose; table sugar is ineffective in this context. Prior to commencing therapy, inform your physician of any hepatic or renal dysfunction. The medication is contraindicated in individuals with gastrointestinal ulceration or inflammation (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating women should seek medical advice before use. Complete disclosure of all concurrent medications is essential for safety. Limit alcohol consumption during treatment to mitigate the risk of hypoglycemia.
Primary Ingredients of Mignar 25 Tablet
No text provided to rephrase.
Uses of Mignar 25 Tablet
Managing Type 2 diabetes
Major Benefits of Mignar 25 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mignar 25 Tablets should be administered with a meal.
Common Side effects of Mignar 25 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Mignar 25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mignar 25 Tablet whole; avoid crushing, chewing, or breaking it. It should be administered with food.
How Mignar 25 Tablet works:
Glucovance 25mg tablets are used to manage diabetes. They work by blocking enzymes in the intestines that digest complex carbohydrates into simple sugars like glucose, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Mignar 25 Tablet.
PregnancySAFE IF PRESCRIBED
The use of Mignar 25 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on limited available data from humans, the use of Mignar 25 Tablet while breastfeeding is likely safe, posing minimal apparent risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mignar 25 Tablet.
KidneyCAUTION
Patients with kidney impairment should use Mignar 25 Tablet cautiously, potentially requiring dosage modification under medical supervision. Mignar 25 Tablet is contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
Use of Mignar 25 Tablet in individuals with liver conditions appears to present minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Mignar 25 Tablet :
Omit any missed Mignar 25 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Mignar 25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Nojirimycin Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
| Actions | Alpha-glucosidase inhibitors |





